Huang, S.-P.; Chen, Y.-T.; Chen, L.-C.; Lee, C.-H.; Huang, C.-Y.; Yu, C.-C.; Lin, V.C.; Lu, T.-L.; Bao, B.-Y.
NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer. Biomedicines 2021, 9, 528.
https://doi.org/10.3390/biomedicines9050528
AMA Style
Huang S-P, Chen Y-T, Chen L-C, Lee C-H, Huang C-Y, Yu C-C, Lin VC, Lu T-L, Bao B-Y.
NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer. Biomedicines. 2021; 9(5):528.
https://doi.org/10.3390/biomedicines9050528
Chicago/Turabian Style
Huang, Shu-Pin, Yei-Tsung Chen, Lih-Chyang Chen, Cheng-Hsueh Lee, Chao-Yuan Huang, Chia-Cheng Yu, Victor C. Lin, Te-Ling Lu, and Bo-Ying Bao.
2021. "NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer" Biomedicines 9, no. 5: 528.
https://doi.org/10.3390/biomedicines9050528
APA Style
Huang, S.-P., Chen, Y.-T., Chen, L.-C., Lee, C.-H., Huang, C.-Y., Yu, C.-C., Lin, V. C., Lu, T.-L., & Bao, B.-Y.
(2021). NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer. Biomedicines, 9(5), 528.
https://doi.org/10.3390/biomedicines9050528
